1. Home
  2. HCWC vs CNSP Comparison

HCWC vs CNSP Comparison

Compare HCWC & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCWC
  • CNSP
  • Stock Information
  • Founded
  • HCWC N/A
  • CNSP 2017
  • Country
  • HCWC
  • CNSP United States
  • Employees
  • HCWC N/A
  • CNSP N/A
  • Industry
  • HCWC
  • CNSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • HCWC
  • CNSP Health Care
  • Exchange
  • HCWC NYSE
  • CNSP Nasdaq
  • Market Cap
  • HCWC 7.4M
  • CNSP 6.5M
  • IPO Year
  • HCWC N/A
  • CNSP 2019
  • Fundamental
  • Price
  • HCWC $0.74
  • CNSP $3.23
  • Analyst Decision
  • HCWC
  • CNSP Strong Buy
  • Analyst Count
  • HCWC 0
  • CNSP 1
  • Target Price
  • HCWC N/A
  • CNSP $0.50
  • AVG Volume (30 Days)
  • HCWC N/A
  • CNSP 45.4M
  • Earning Date
  • HCWC N/A
  • CNSP 03-31-2025
  • Dividend Yield
  • HCWC N/A
  • CNSP N/A
  • EPS Growth
  • HCWC N/A
  • CNSP N/A
  • EPS
  • HCWC N/A
  • CNSP N/A
  • Revenue
  • HCWC N/A
  • CNSP N/A
  • Revenue This Year
  • HCWC N/A
  • CNSP N/A
  • Revenue Next Year
  • HCWC N/A
  • CNSP N/A
  • P/E Ratio
  • HCWC N/A
  • CNSP N/A
  • Revenue Growth
  • HCWC N/A
  • CNSP N/A
  • 52 Week Low
  • HCWC N/A
  • CNSP $2.81
  • 52 Week High
  • HCWC N/A
  • CNSP $1,195.00
  • Technical
  • Relative Strength Index (RSI)
  • HCWC N/A
  • CNSP 35.22
  • Support Level
  • HCWC N/A
  • CNSP $4.60
  • Resistance Level
  • HCWC N/A
  • CNSP $9.50
  • Average True Range (ATR)
  • HCWC 0.00
  • CNSP 0.94
  • MACD
  • HCWC 0.00
  • CNSP -0.15
  • Stochastic Oscillator
  • HCWC 0.00
  • CNSP 6.28

About HCWC HEALTHY CHOICE WELLNESS CORP

Healthy Choice Wellness Corp is a company engaged in providing consumers with healthier daily choices with respect to nutrition and other lifestyle alternatives. The company has one reportable segment which is natural and organic retail stores.

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

Share on Social Networks: